Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro

Neurodegenerative Diseases

Volumn 5, Issue 3-4, 2008, Pages 232-236

  Podoly, E ^a   Bruck, T ^a   Diamant, S ^a   Melamed Book, N ^a   Weiss, A ^b   Huang, Y ^c   Livnah, O ^a   Langermann, S ^c   Wilgus, H ^c   Soreq, H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c PharmAthene Inc   (United States)

Author keywords

Amyloid; Alzheimer's disease; Human recombinant butyrylcholinesterase

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINESTERASE; DIMER; RECOMBINANT ENZYME; TETRAMER; THIOFLAVINE;

CONFERENCE PAPER; CROSS LINKING; ENZYME PURIFICATION; IN VITRO STUDY; MILK; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSGENIC GOAT; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BUTYRYLCHOLINESTERASE; FEMALE; GOATS; HUMANS; MILK; RECOMBINANT PROTEINS;

EID: 40449118768     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000113711     Document Type: Conference Paper

References (20)

1. Dickson DW: The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56:321-339.
2. Mi K, Johnson GV: The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2006;3:449-463.
3. Jbilo O, et al: Tissue distribution of human acetylcholinesterase and butyrylcholinesterase messenger RNA. Toxicon 1994;32:1445-1457.
4. Lockridge O, La Du BN: Amino acid sequence of the active site of human serum cholinesterase from usual, atypical, and atypical-silent genotypes. Biochem Genet 1986;24:485-498.
5. Darvesh S, Hopkins DA: Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus. J Comp Neurol 2003;463:25-43.
6. Glick D, Ben Moyal L, Soreq H: Genetic variation in butyrylcholinesterase and the physiological consequences for acetylcholinesterase function; in Giacobini E (ed): Butyrylcholinesterase: Function and Inhibition. London, Martin Dunitz, 2003, pp 55-67.
7. Ballard C, et al: The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dement Geriatr Cogn Disord 2005;19:357-360.
8. Carson KA, Geula C, Mesulam MM: Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Brain Res 1991;540:204-208.
9. Guillozet AL, et al: Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol 1997;42:909-918.
10. Wright CI, Geula C, Mesulam MM: Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Ann Neurol 1993;34:373-384.
11. Cummings BJ, et al: Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging 1996;17:921-933.
12. Geula C, Mesulam MM: Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9(suppl 2):23-28.
13. Perry EK, et al: Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 1978;4:273-277.
14. Rao AA, Sridhar GR, Das UN: Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med Hypotheses 2007;69:1272-1276.
15. Diamant S, et al: Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci USA 2006;103:8628-8633.
16. Cerasoli DM, et al: In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chem Biol Interact 2005;157-158:363-365.
17. Cai K, et al: Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens. BioDrugs 2005;19:79-96.
18. Fancy DA, Kodadek T: Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci USA 1999;96:6020-6024.
19. Fancy DA, et al: Scope, limitations and mechanistic aspects of the photo-induced cross-linking of proteins by water-soluble metal complexes. Chem Biol 2000;7:697-708.
20. Goldsbury CS, et al: Studies on the in vitro assembly of Abeta 1-40: implications for the search for Abeta fibril formation inhibitors. J Struct Biol 2000;130:217-231.